Sex-stratified comparisons of people with DLB to controls in Malmö Alzheimer Study, showed lower CSF alpha-synuclein and orexin levels particularly for females, supporting the utility for sex-specific biomarkers [65]. The gene discussed is SNCA; the disease is Lewy body dementia.